STSA

Satsuma Pharmaceuticals, Inc. Common Stock

Delisted

STSA was delisted on the 7th of June, 2023.

36 hedge funds and large institutions have $296M invested in Satsuma Pharmaceuticals, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 15 increasing their positions, 9 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
36
Holders Change
+4
Holders Change %
+12.5%
% of All Funds
0.8%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
6
Increased
15
Reduced
9
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
Bank of America
26
Bank of America
North Carolina
$79K +$63.9K +2,978 +425%
Wells Fargo
27
Wells Fargo
California
$70K +$62.3K +2,881 +805%
AIG
28
American International Group
New York
$57K -$2.67K -124 -4%
Victory Capital Management
29
Victory Capital Management
Texas
$46K +$46K +2,162 New
Deutsche Bank
30
Deutsche Bank
Germany
$36K +$4.19K +195 +13%
Citigroup
31
Citigroup
New York
$27K +$7.94K +370 +42%
SO
32
STRS Ohio
Ohio
$23K
Legal & General Group
33
Legal & General Group
United Kingdom
$11K -$7.37K -365 -40%
AIP
34
Ameritas Investment Partners
Nebraska
$8K
UBS Group
35
UBS Group
Switzerland
$6K -$117K -5,449 -95%
Royal Bank of Canada
36
Royal Bank of Canada
Ontario, Canada
$6K +$374 +20 +7%
ZP
37
Zimmer Partners
New York
-$1.97M -100,000 Closed
Bank of Montreal
38
Bank of Montreal
Ontario, Canada
-$11K -559 Closed